Molekule Group Stock Net Income
Molekule Group fundamentals help investors to digest information that contributes to Molekule's financial success or failures. It also enables traders to predict the movement of Molekule Stock. The fundamental analysis module provides a way to measure Molekule's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molekule stock.
Molekule |
Molekule Group Company Net Income Analysis
Molekule's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Molekule Net Income | (1.55 M) |
Most of Molekule's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molekule Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Molekule Group reported net income of (1.55 Million). This is 100.6% lower than that of the Machinery sector and 120.98% lower than that of the Industrials industry. The net income for all United States stocks is 100.27% higher than that of the company.
Molekule Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molekule's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molekule could also be used in its relative valuation, which is a method of valuing Molekule by comparing valuation metrics of similar companies.Molekule is currently under evaluation in net income category among its peers.
Molekule Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.47) % | |||
| Current Valuation | 45.01 M | |||
| Shares Outstanding | 34.65 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 30.70 % | |||
| Number Of Shares Shorted | 775.6 K | |||
| Revenue | 48.03 M | |||
| Gross Profit | 277.62 K | |||
| EBITDA | 8.34 M | |||
| Net Income | (1.55 M) | |||
| Total Debt | 46.72 M | |||
| Book Value Per Share | 1.20 X | |||
| Cash Flow From Operations | (41.28 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (0.68) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 91 | |||
| Market Capitalization | 1.87 M | |||
| Total Asset | 52.32 M | |||
| Retained Earnings | (7.92 M) | |||
| Working Capital | 20.22 M | |||
| Z Score | 1.72 | |||
| Net Asset | 52.32 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |